Preprint · CC-BY
via OpenAlex
Reproductive Aging, FSH, APO Lipoproteins, and Alzheimer’s Disease: Endocrine Mechanisms Linking Reproductive Aging to Neurodegeneration
Preprints.org · 2026
Abstract
Alzheimer’s disease (AD) is more common in women than men and the risk of AD increases markedly during and after the menopausal transition. Although a role for estrogen deficiency is well studied, recent reports have revealed the pivotal but under-recognized contribution of follicle-stimulating hormone (FSH) in mediating neurodegenerative risk. In this review, we integrate current understanding of reproductive aging, AD pathobiology, and sex differences with a specific emphasis on endocrine, metabolic and inflammatory processes. FSH increases during reproductive aging and has mechanistic connections to several canonical molecular pathways that are altered in AD. This includes signaling through C/EBPβ-δ-secretase, mitochondria, glucose metabolism, and the autophagic/lysosomal clearance pathway. The convergence of these processes appears to underlie aspects of amyloid-β (Aβ) accumulation, tau pathology, and chronic neuroinflammation. FSH also modulates apolipoprotein biology (e.g., ApoE) by impacting lipid metabolism, protein lipidation, and clearance, which in turn affects Aβ kinetics and neuroinflammation in an ApoE isoform-specific manner. In addition, reproductive aging is associated with changes in vascular health and permeability, blood-brain barrier function, and immunometabolic processes that may drive neurodegenerative risk. Critically, these early upstream events drive disease risk before the onset of the more classical pathological features, which may shift our current perception of Aβ and tau as causes of AD to instead be consequences of upstream failure. Overall, this review provides mechanistic insight into the role of FSH and its downstream signaling pathways in neurodegeneration. As such, modulating FSH signaling and downstream pathways is a promising and mechanistically supported therapeutic strategy for reducing AD risk in women.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.20944/preprints202604.0104.v2
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Muhammad, Y.A. (2026). Reproductive Aging, FSH, APO Lipoproteins, and Alzheimer’s Disease: Endocrine Mechanisms Linking Reproductive Aging to Neurodegeneration. <em>Preprints.org</em>. https://doi.org/10.20944/preprints202604.0104.v2
Vancouver
Muhammad YA. Reproductive Aging, FSH, APO Lipoproteins, and Alzheimer’s Disease: Endocrine Mechanisms Linking Reproductive Aging to Neurodegeneration. Preprints.org. 2026. doi:10.20944/preprints202604.0104.v2.
BibTeX
@unpublished{yasin2026Reprod,
title = {Reproductive Aging, FSH, APO Lipoproteins, and Alzheimer’s Disease: Endocrine Mechanisms Linking Reproductive Aging to Neurodegeneration},
author = {Yasin Ali Muhammad},
journal = {Preprints.org},
year = {2026},
doi = {10.20944/preprints202604.0104.v2},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Preprints.org 2026
Preprint · CC-BY
Reproductive Aging, FSH, APO Proteins, and Alzheimer’s Disease: Endocrine Mechanisms Linking Ovarian Decline to Neurodegeneration
Pharmaceuticals (Basel, Switzerland) 2025
Open access · OA
Sirtuins in Women's Health.
Basic & clinical pharmacology & toxicology 2026
Open access · OA
The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective.
Pathophysiology : the official journal of the International Society for Pathophysiology 2026
Open access · OA
Sleep and the Gut-Brain Axis: Bidirectional, Converging Mechanisms Linking Brain Health, Neuroinflammation, and Neurodegeneration.
Diabetologia 2023
Open access · CC-BY
Sex differences in type 2 diabetes
Journal of Applied Toxicology 2026
Citation only